Edwards Lifesciences SG&A Expenses 2010-2025 | EW
Edwards Lifesciences annual/quarterly sg&a expenses history and growth rate from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Edwards Lifesciences sg&a expenses for the quarter ending March 31, 2025 were $0.466B, a 8.71% increase year-over-year.
- Edwards Lifesciences sg&a expenses for the twelve months ending March 31, 2025 were $1.827B, a 16% increase year-over-year.
- Edwards Lifesciences annual sg&a expenses for 2024 were $1.789B, a 13.06% increase from 2023.
- Edwards Lifesciences annual sg&a expenses for 2023 were $1.583B, a 16.57% increase from 2022.
- Edwards Lifesciences annual sg&a expenses for 2022 were $1.358B, a 9.11% decline from 2021.
| Edwards Lifesciences Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,789 |
| 2023 | $1,583 |
| 2022 | $1,358 |
| 2021 | $1,494 |
| 2020 | $1,228 |
| 2019 | $1,242 |
| 2018 | $1,089 |
| 2017 | $991 |
| 2016 | $905 |
| 2015 | $851 |
| 2014 | $858 |
| 2013 | $733 |
| 2012 | $697 |
| 2011 | $642 |
| 2010 | $550 |
| 2009 | $509 |
| Edwards Lifesciences Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $466 |
| 2024-12-31 | $489 |
| 2024-09-30 | $421 |
| 2024-06-30 | $451 |
| 2024-03-31 | $428 |
| 2023-12-31 | $354 |
| 2023-09-30 | $382 |
| 2023-06-30 | $410 |
| 2023-03-31 | $436 |
| 2022-12-31 | $201 |
| 2022-09-30 | $377 |
| 2022-06-30 | $409 |
| 2022-03-31 | $370 |
| 2021-12-31 | $424 |
| 2021-09-30 | $364 |
| 2021-06-30 | $375 |
| 2021-03-31 | $331 |
| 2020-12-31 | $339 |
| 2020-09-30 | $307 |
| 2020-06-30 | $275 |
| 2020-03-31 | $308 |
| 2019-12-31 | $347 |
| 2019-09-30 | $306 |
| 2019-06-30 | $309 |
| 2019-03-31 | $280 |
| 2018-12-31 | $288 |
| 2018-09-30 | $270 |
| 2018-06-30 | $275 |
| 2018-03-31 | $256 |
| 2017-12-31 | $273 |
| 2017-09-30 | $245 |
| 2017-06-30 | $244 |
| 2017-03-31 | $230 |
| 2016-12-31 | $234 |
| 2016-09-30 | $230 |
| 2016-06-30 | $229 |
| 2016-03-31 | $213 |
| 2015-12-31 | $222 |
| 2015-09-30 | $212 |
| 2015-06-30 | $214 |
| 2015-03-31 | $203 |
| 2014-12-31 | $223 |
| 2014-09-30 | $222 |
| 2014-06-30 | $216 |
| 2014-03-31 | $197 |
| 2013-12-31 | $187 |
| 2013-09-30 | $178 |
| 2013-06-30 | $187 |
| 2013-03-31 | $182 |
| 2012-12-31 | $170 |
| 2012-09-30 | $168 |
| 2012-06-30 | $182 |
| 2012-03-31 | $177 |
| 2011-12-31 | $163 |
| 2011-09-30 | $166 |
| 2011-06-30 | $163 |
| 2011-03-31 | $150 |
| 2010-12-31 | $142 |
| 2010-09-30 | $133 |
| 2010-06-30 | $141 |
| 2010-03-31 | $134 |
| 2009-12-31 | $132 |
| 2009-09-30 | $126 |
| 2009-06-30 | $129 |
| 2009-03-31 | $122 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.083B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.575B | 80.41 |
| Thermo Fisher Scientific (TMO) | United States | $152.039B | 18.39 |
| Alcon (ALC) | Switzerland | $42.518B | 28.73 |
| IDEXX Laboratories (IDXX) | United States | $42.037B | 48.31 |
| DexCom (DXCM) | United States | $32.149B | 49.69 |
| IQVIA Holdings (IQV) | United States | $27.142B | 15.20 |
| Mettler-Toledo (MTD) | United States | $24.013B | 28.56 |
| STERIS (STE) | Ireland | $23.741B | 26.15 |
| Waters (WAT) | United States | $20.370B | 28.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.723B | 0.00 |
| Hologic (HOLX) | United States | $14.429B | 15.68 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.933B | 77.96 |
| Masimo (MASI) | United States | $8.740B | 32.24 |
| Globus Medical (GMED) | United States | $7.974B | 19.00 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| TransMedics (TMDX) | United States | $4.833B | 105.06 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.355B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.86 |
| Nihon Kohden (NHNKY) | Japan | $2.264B | 25.96 |
| Veracyte (VCYT) | United States | $2.071B | 29.05 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.617B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.383B | 0.00 |
| Artivion (AORT) | United States | $1.206B | 113.00 |
| Pulse Biosciences (PLSE) | United States | $1.061B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.945B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.828B | 0.00 |
| SiBone (SIBN) | United States | $0.742B | 0.00 |
| IRadimed (IRMD) | United States | $0.740B | 37.53 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| Delcath Systems (DCTH) | United States | $0.534B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 12.42 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| AxoGen (AXGN) | United States | $0.444B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.433B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.431B | 0.00 |
| NeuroPace (NPCE) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.330B | 8.78 |
| ClearPoint Neuro (CLPT) | United States | $0.323B | 0.00 |
| 908 Devices (MASS) | United States | $0.262B | 0.00 |
| Neuronetics (STIM) | United States | $0.249B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.183B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.10 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.35 |